![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmaco-Biochemistry and 21COE, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan (J.S., S.N., K.Y., K.Y., M.M.); and Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina (T.S., M.N.)
Abstract
UDP-glucuronosyltransferase (UGT) 1A1 glucuronidates endogenous metabolites, such as bilirubin, and exogenous substances, and plays a critical role in their detoxification and excretion. In a previous article, we described the phenobarbital response activity to a 290-base pair (bp) distal enhancer sequence (–3499/–3210) of the human UGT1A1 gene that is activated by the constitutive androstane receptor (CAR). Here, we show that dexamethasone at submicromolar concentrations enhances the pregnane X receptor (PXR) activator-mediated expression of the UGT1A1 gene and protein in HepG2 cells. We investigated the molecular mechanism of UGT1A1 induction by glucocorticoids at submicromolar concentrations and PXR activators and the functional cross-talk between the glucocorticoid receptor (GR) and CAR/PXR. The glucocorticoid-response element (GRE) was characterized by cotransfection experiments, site-directed mutagenesis, and electrophoretic mobility shift assays. Analysis of the human UGT1A1 promoter revealed GREs at –3404/–3389 and –3251/–3236 close to the CAR/PXR response element gtNR1 (–3382/–3367). Furthermore, in an in vitro reporter gene assay, dexamethasone effectively enhanced CAR/PXR-mediated transactivation of the 290-bp distal enhancer module in HepG2 cells and CV-1 cells in the presence of exogenously expressed GR and glucocorticoid receptor-interacting protein 1 (GRIP1). In glutathione S-transferase pull-down experiments, CAR and PXR interacted with GRIP1. Together, these results demonstrate a rational mechanistic basis for UGT1A1 induction by glucocorticoids and PXR activators, showing that activated GR enhances CAR/PXR-mediated UGT1A1 regulation with the transcriptional cofactor GRIP1 and that GR may be involved synergistically in the xenobiotic-responsive regulation of UGT1A1 by CAR/PXR.
Address correspondence to: Dr. Masao Miwa, Department of Pharmaco-Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422]hyphen]8526, Japan. E-mail: miwa{at}u-shizuoka-ken.ac.jp
This article has been cited by other articles:
|
|
 |
|
  L. A. Wenning, W. D. Hanley, D. M. Brainard, A. S. Petry, K. Ghosh, B. Jin, E. Mangin, T. C. Marbury, J. K. Berg, J. A. Chodakewitz, et al. Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2852 - 2856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Buckley and C. D. Klaassen Induction of Mouse UDP-Glucuronosyltransferase mRNA Expression in Liver and Intestine by Activators of Aryl-Hydrocarbon Receptor, Constitutive Androstane Receptor, Pregnane X Receptor, Peroxisome Proliferator-Activated Receptor {alpha}, and Nuclear Factor Erythroid 2-Related Factor 2 Drug Metab. Dispos., April 1, 2009; 37(4): 847 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iwamoto, L. A. Wenning, A. S. Petry, M. Laethem, M. De Smet, J. T. Kost, S. A. Breidinger, E. C. Mangin, N. Azrolan, H. E. Greenberg, et al. Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4338 - 4343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I. Sims, C. B. Baughman, and G. R. Schnitzler Human SWI/SNF directs sequence-specific chromatin changes on promoter polynucleosomes Nucleic Acids Res., November 1, 2008; 36(19): 6118 - 6131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sandanaraj, S. Lal, V. Selvarajan, L. L. Ooi, Z. W. Wong, N. S. Wong, P. C. S. Ang, E. J.D. Lee, and B. Chowbay PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients Clin. Cancer Res., November 1, 2008; 14(21): 7116 - 7126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Osabe, J. Sugatani, T. Fukuyama, S.-i. Ikushiro, A. Ikari, and M. Miwa Expression of Hepatic UDP-Glucuronosyltransferase 1A1 and 1A6 Correlated with Increased Expression of the Nuclear Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor {alpha} in Male Rats Fed a High-Fat and High-Sucrose Diet Drug Metab. Dispos., February 1, 2008; 36(2): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-F. Yueh and R. H. Tukey Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice J. Biol. Chem., March 23, 2007; 282(12): 8749 - 8758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Senekeo-Effenberger, S. Chen, E. Brace-Sinnokrak, J. A. Bonzo, M.-F. Yueh, U. Argikar, J. Kaeding, J. Trottier, R. P. Remmel, J. K. Ritter, et al. Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor {alpha} Activation Drug Metab. Dispos., March 1, 2007; 35(3): 419 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor Pharmacol. Rev., December 1, 2006; 58(4): 742 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sugatani, T. Wada, M. Osabe, K. Yamakawa, K. Yoshinari, and M. Miwa Dietary Inulin Alleviates Hepatic Steatosis and Xenobiotics-Induced Liver Injury in Rats Fed a High-Fat and High-Sucrose Diet: Association with the Suppression of Hepatic Cytochrome P450 and Hepatocyte Nuclear Factor 4{alpha} Expression Drug Metab. Dispos., October 1, 2006; 34(10): 1677 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ding, K. Lichti, I. Kim, F. J. Gonzalez, and J. L. Staudinger Regulation of Constitutive Androstane Receptor and Its Target Genes by Fasting, cAMP, Hepatocyte Nuclear Factor {alpha}, and the Coactivator Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha} J. Biol. Chem., September 8, 2006; 281(36): 26540 - 26551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duret, M. Daujat-Chavanieu, J.-M. Pascussi, L. Pichard-Garcia, P. Balaguer, J.-M. Fabre, M.-J. Vilarem, P. Maurel, and S. Gerbal-Chaloin Ketoconazole and Miconazole Are Antagonists of the Human Glucocorticoid Receptor: Consequences on the Expression and Function of the Constitutive Androstane Receptor and the Pregnane X Receptor Mol. Pharmacol., July 1, 2006; 70(1): 329 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chen, D. Beaton, N. Nguyen, K. Senekeo-Effenberger, E. Brace-Sinnokrak, U. Argikar, R. P. Remmel, J. Trottier, O. Barbier, J. K. Ritter, et al. Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus J. Biol. Chem., November 11, 2005; 280(45): 37547 - 37557. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
